211 related articles for article (PubMed ID: 24296797)
21. Increased apoptosis and secretion of tryptase by mast cells in infantile haemangioma treated with propranolol.
Steel R; Day D
Pathology; 2014 Oct; 46(6):496-500. PubMed ID: 25158819
[TBL] [Abstract][Full Text] [Related]
22. Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol.
Campanelli R; Codazzi AC; Poletto V; Abbà C; Catarsi P; Fois G; Avanzini MA; Brazzelli V; Tzialla C; De Silvestri A; Tinelli C; Licari A; Berra-Romani R; Zuccolo E; Moccia F; Mannarino S; Rosti V; Massa M
Thromb Haemost; 2019 Feb; 119(2):274-284. PubMed ID: 30609443
[TBL] [Abstract][Full Text] [Related]
23. Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.
Lorusso B; Cerasoli G; Falco A; Frati C; Graiani G; Madeddu D; Nogara A; Corradini E; Roti G; Cerretani E; Gherli A; Caputi M; Gnetti L; Pilato FP; Quaini F; Lagrasta C
Vascul Pharmacol; 2022 Oct; 146():107110. PubMed ID: 36103993
[TBL] [Abstract][Full Text] [Related]
24. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
25. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.
Rotter A; de Oliveira ZNP
J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649
[TBL] [Abstract][Full Text] [Related]
26. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
[TBL] [Abstract][Full Text] [Related]
27. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
[TBL] [Abstract][Full Text] [Related]
28. Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway.
Yao TH; Pataer P; Regmi KP; Gu XW; Li QY; Du JT; Ge SM; Tu JB
Mol Med Rep; 2018 Jul; 18(1):684-694. PubMed ID: 29767244
[TBL] [Abstract][Full Text] [Related]
29. [The advance of β-blockers in the treatment of infantile hemangiomas].
Lin TT; He YJ
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1138-44. PubMed ID: 24499701
[TBL] [Abstract][Full Text] [Related]
30. Propranolol suppresses HUVEC viability, migration, VEGF expression, and promotes apoptosis by downregulation of miR-4295.
Zhao F; Yang X; Xu G; Bi J; Lv R; Huo R
J Cell Biochem; 2019 Apr; 120(4):6614-6623. PubMed ID: 30368887
[TBL] [Abstract][Full Text] [Related]
31. [Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma].
Yuan WL; Wang XK
Shanghai Kou Qiang Yi Xue; 2022 Aug; 31(4):400-405. PubMed ID: 36710554
[TBL] [Abstract][Full Text] [Related]
32. The effects of propranolol on the biology and Notch signaling pathway of human umbilical vein endothelial cells.
Chen S; Zhao X; Huang J; Lin N; Xu Q; Chen J; Huang J; Wang L; Lin C; Zhang Z
Medicine (Baltimore); 2023 Aug; 102(32):e34672. PubMed ID: 37565874
[TBL] [Abstract][Full Text] [Related]
33. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
[TBL] [Abstract][Full Text] [Related]
34. Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.
Chen Q; Ying H; Yu Z; Chang L; Chen Z; Chen J; Chang SJ; Qiu Y; Lin X
J Invest Dermatol; 2023 Apr; 143(4):566-577.e12. PubMed ID: 36243122
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
[TBL] [Abstract][Full Text] [Related]
36. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
37. Propranolol Accelerats Hemangioma Stem Cell Transformation Into Adipocyte.
Li HH; Lou Y; Zhang RR; Xie J; Cao DS
Ann Plast Surg; 2019 Nov; 83(5):e5-e13. PubMed ID: 31609806
[TBL] [Abstract][Full Text] [Related]
38. Propranolol responsiveness in vascular tumors is not determined by qualitative differences in adrenergic receptors.
Boucek RJ; Kirsh AL; Majesky MW; Perkins JA
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):772-6. PubMed ID: 24009211
[TBL] [Abstract][Full Text] [Related]
39. Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.
Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
Oncol Rep; 2018 Jan; 39(1):109-118. PubMed ID: 29192323
[TBL] [Abstract][Full Text] [Related]
40. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
